Defensive stocks
Goldman Sachs issued buy calls on Nvidia, Samsara, BrightSpring, Ulta Beauty, and Johnson & Johnson, framing them as defensive growth with upside. CNBC highlights Nvidia's sustained growth into 2027 and J&J's $80bn balance sheet for M&A. Samsara is called 'one of the most defensible growth assets in software,' and BrightSpring has surged 67% YTD in aging-care services. The thesis is a bet on quality and resilience amid market choppiness.
Buy Nvidia — Goldman reiterates Buy rating with sustained AI growth into 2027, and the stock is 13% below its 52-week high with a 16.1x forward P/E—not stretched.
Buy Samsara — Called 'defensible growth' with expanding margins; last session +4.34% shows momentum but YTD flat suggests room to recover.
Buy BrightSpring — Initiated with Buy, aging-care premium growth; 2% below 52-week high after 65% YTD run—momentum but valuation risk.
Buy Ulta Beauty — Goldman says buy the dip on margin concerns, with comp acceleration expected; 35% below 52-week high, forward P/E 14.7x.
Buy Johnson & Johnson — Strong pharma franchise and $80bn M&A capacity; near 52-week high but 18.9x forward P/E provides support.